2005
DOI: 10.1016/j.jss.2005.05.021
|View full text |Cite
|
Sign up to set email alerts
|

Beneficial Effects of Intravenous Administration of Lipo-Prostaglandin E1 on the Ischemic Gastric Tube in Pigs

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
7
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 24 publications
0
7
0
Order By: Relevance
“…This coating protects PGE1 from being rapidly metabolized 12 . In our previous study, 13 TBF on ischemic site of the gastric tube after lipo‐PGE1 administration was significantly increased and maintained over 10 mL/min/100 g until 10 minutes after the end of administration. In this article, we investigate how long the beneficial effects of intravenous administration of lipo‐PGE1 on the ischemic gastric tube continue.…”
Section: Introductionmentioning
confidence: 82%
“…This coating protects PGE1 from being rapidly metabolized 12 . In our previous study, 13 TBF on ischemic site of the gastric tube after lipo‐PGE1 administration was significantly increased and maintained over 10 mL/min/100 g until 10 minutes after the end of administration. In this article, we investigate how long the beneficial effects of intravenous administration of lipo‐PGE1 on the ischemic gastric tube continue.…”
Section: Introductionmentioning
confidence: 82%
“…Some researchers have coated PGE 1 in lipid microspheres (lipo-PGE 1 ) to protect it from rapid metabolism in the lungs and give fewer side-effects. 20 Nishimura et al 17 showed no obvious differences between the effects of PGE 1 and lipo-PGE 1 on systematic blood pressure and cochlear blood flow, so our meta-analysis combined studies on PGE 1 and lipo-PGE 1 .…”
Section: Discussionmentioning
confidence: 98%
“…Lipo‐PGE 1 was developed with one of these approaches as a targeting‐type drug delivery system. This approach was shown to be effective to deliver a sufficient amount of PGE 1 to the lesional site,12,14,15 and thus, several commercial products of PGE 1 are currently available as solutions of lipo‐PGE 1. However, it should be noted that the pharmacological potency of lipo‐PGE 1 varies significantly depending on which clinical solution the original lipo‐PGE 1 solution is mixed with.…”
Section: Discussionmentioning
confidence: 99%
“…PGE 1 is dissolved into the o/w lipid emulsion containing these lipid microspheres, and then it is spontaneously incorporated by the microspheres because of its lipophilicity 12,13. It was demonstrated that the lipid microspheres effectively carry PGE 1 to the vascular lesion site, and that lipo‐PGE 1 exerts a more potent pharmacological effect than free PGE 1 12,14,15…”
Section: Introductionmentioning
confidence: 99%